Benjamin Rapoport, one of Neuralink's co founders along with Elon Musk, has parted ways with the brain computer interface company over security concerns. This was revealed in an interview with the Wall Street Journal podcast The Future of Everything.

Although Rapoport, a neurosurgeon by profession, has devoted much of his career to advancing the neural interface from science to medicine, He explained that safety had to be prioritized when merging medicine with technology. His departure from Neuralink led to the founding of his venture, Precision Neuroscience. Rapoport's main concern is that they use these little electrodes that go into the brain to get information about how Neuralink does its job, but Rapoport thinks that's dangerous because it can damage the brain.

On the other hand, his new company, Precision Neuroscience, uses different electrodes that sit on the surface of the brain rather than going inside. In this way, they hope to make the process less risky and safer for people. I have dedicated my professional life to bringing neural interfaces from the world of science to the world of medicine. But going into the world of medicine and technology, I thought safety was important,'' Rapaport said. For a medical device, safety often means less invasiveness, continued Rapaport.

In the early days of brain computer interfaces, it was thought that to extract information rich data from the brain, it was necessary to penetrate the brain with the tiny needle like electrodes. Despite attempts to reach both Rapoport and Neuralink for further comment, there was no response at the time of reporting. As debate continues around the safety and ethics of brain computer interfaces, Rapoport's departure underscores the importance of prioritizing safety in the pursuit of technological innovation.